During BioBusiness Event 2008, four Roundtable Discussions will be organised around themes that are essential to biotech and pharma companies. All participants of BioBusiness Event can participate in the Roundtables without additional costs. However, the number of participants is limited to a maximum of 15 persons for each Roundtable. In case more registrations are received, a selection by the discussion leader will take place.
The following Roundtables will take place on 21 May:
How to develop your bio-pharmaceutical invention to a drug product
Frans Lichtenauer, Director Business Development BioConnection
11.00 - 11.45
Funding opportunities for biotech & pharma companies
Corjan Visser, Managing Consultant PNO Consultants
Dinko Valerio, General Partner Aescap Ventures
11.45 - 12.30
The optimal Clinical trial for global registrations
Louis van de Ven, CMO and Managing Director Clinquest Europe
13.30 - 14.15
Hajo Kraak, Senior Patent Attorney Vereenigde
14.45 - 15.00
Return










